drugset / Trial / NCT04190173

Efficacy of PRUcalopride in Critically Ill Patients With Paralytic ILeus

NCT04190173

Phase 3 Unknown 62 enrolled Prince of Songkla University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Paralytic ileus is a common intestinal dysfunction in critically ill patients. There are still no established the effective medications except correcting the primary causes and prokinetics trial which limited in efficacy and potential adverse events.

Timeline

Start
2017-07-01
Primary completion
2020-01-30
Completion
2020-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Prucalopride Small molecule 1 mg Oral
Subject Prucalopride Small molecule 2 mg Oral